Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

Yomna Eissa, Hyeoung-Joon Kim, Joon Ho Moon, Robert Zeiser, Francesca Biavasco, Christopher Lemieux, Mohamed Elemary, Varun Mehra, Mili Shah, Ahmed Alotaibi, Yu Cai, Xianmin Song, Jae-Sook Ahn, Sang Kyun Sohn, Mohsen Al Zahrani, Muhned Alhumaid, Hee-Je Kim, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 778.

https://doi.org/10.1182/blood-2024-208622

Published: 2024

Journal Articles

The Parous Female Donor Is Not Inferior to Young Male Donor for Haploidentical Peripheral Blood Stem Cell Transplantation with Low-Dose ATG Plus Low-Dose Ptcy-Based Regimen for Gvhd Prophylaxis

Jingjing Cao, Chongmei Huang, Xingying Li, Yu Cai, Kun Zhou, Jun Yang, Xiaowei Xu, Huiying Qiu, Jiahua Niu, Ying Zhang, Xinxin Xia, Yu Wei, Chang Shen, Yin Tong, Baoxia Dong, Liping Wan, Xianmin Song

Blood (2024) 144 (Supplement 1): 7388.

https://doi.org/10.1182/blood-2024-205154

Published: 2024

Journal Articles

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Blood (2024) 144 (Supplement 1): 7418.

https://doi.org/10.1182/blood-2024-206153

Published: 2024

Journal Articles

Haploidentical Peripheral Blood Stem Cell Transplantation Improves the Survival of Older Patients with Myeloid Malignancies Under Low-Dose Antithymocyte Globin (ATG)/Post-Cyclophosphamide (PTCy)-Based Regimen for Graft-Versus-Host Disease Prophylaxis

Yannan Jia, Xinxin Xia, Jun Yang, Yu Cai, Yin Tong, Chongmei Huang, Huiying Qiu, Kun Zhou, Ying Zhang, Chang Shen, Liping Wan, Xianmin Song

Blood (2024) 144 (Supplement 1): 7357.

https://doi.org/10.1182/blood-2024-201952

Published: 2024

Journal Articles

IM2 Regimen Is Effective and Safe for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma/Leukemia

Shixuan Tang, Jiahua Niu, Xinxin Xia, Chongmei Huang, Huiying Qiu, Ying Zhang, Xiaowei Xu, Chang Shen, Yu Wei, Jun Yang, Kun Zhou, Yin Tong, Yu Cai, Baoxia Dong, Liping Wan, Xianmin Song

Blood (2024) 144 (Supplement 1): 5879.

https://doi.org/10.1182/blood-2024-200749

Published: 2024

Journal Articles

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Blood (2024) 144 (Supplement 1): 2187.

https://doi.org/10.1182/blood-2024-206919

Published: 2024

Journal Articles

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Eshrak Al-Shaibani, Yu Cai, Xianmin Song, Mohsen Al Zahrani, Mohamed Elemary, Muhned Alhumaid, Hanan Alkhaldi, Ayman Saad, Francesca Biavasco, Robert Zeiser, Joon Ho Moon, Sang Kyun Sohn, Jonas Mattsson, Dennis Dong Hwan Kim

Blood (2024) 144 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2024-211761

Published: 2024

Journal Articles

Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database

Frank Snopek, Ali Seddighzadeh, Megan Flynn, Ling-Yu Cai, Esther Chen, Weichung Joe Shih, Albert Qin, Raymond W Urbanski

Blood (2023) 142 (Supplement 1): 6436.

https://doi.org/10.1182/blood-2023-190344

Published: 2023

Journal Articles

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Huiying Qiu, Qiaomei He, Xi Sun, Ying Wang, Jiahua Niu, Jun Yang, Chongmei Huang, Kun Zhou, Yin Tong, Yu Cai, Baoxia Dong, Liping Wan, Xianmin Song

Blood (2023) 142 (Supplement 1): 3554.

https://doi.org/10.1182/blood-2023-189174

Published: 2023

Journal Articles

Low-Dose Antithymocyte Globulin Plus Low-Dose Post-Transplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after Haploidentical Peripheral Blood Stem Cell Transplants: A Large Sample, Long-Term Follow-up Retrospective Study

Xingying Li, Jun Yang, Liping Wan, Yu CAI, Kun Zhou, Chongmei Huang, Yin Tong, Huiying Qiu, Xianmin Song

Blood (2022) 140 (Supplement 1): 10471–10472.

https://doi.org/10.1182/blood-2022-164983

Published: 2022

Journal Articles

Phase I Study of SHR0302, a Selective JAK1 Inhibitor, Combined with Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease after Allo-HSCT

Huiying Qiu, Jiahua Niu, Xi Sun, Huajun Li, Juan Yang, Chongmei Huang, Yu CAI, Kun Zhou, Yin Tong, Liping Wan, Xianmin Song

Blood (2022) 140 (Supplement 1): 7624.

https://doi.org/10.1182/blood-2022-162148

Published: 2022

Journal Articles

Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improve the Survival of Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Zaihong Shen, Jun Yang, Yu CAI, Liping Wan, Chongmei Huang, Xiaowei Xu, Jiahua Niu, Xinxin Xia, Chang Shen, Huiying Qiu, Kun Zhou, Yin Tong, Xianmin Song

Blood (2022) 140 (Supplement 1): 4723.

https://doi.org/10.1182/blood-2022-163234

Published: 2022

Journal Articles

Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas

Junning Cao, Zhiming Li, MD PhD, Jianfeng Zhou, MD PhD, Dongmei Ji, MD PhD, Weina Shen, PhD, Peng Sun, MD, Yu Wang, MD, Dengju Li, MD, Zhenya Hong, MDPhD, Gaoxiang Wang, MDPhD, Xianlin Duan, MD, Chen Yu, MD, Yu Cai, PhD, Weiguo Su, PhD

Blood (2020) 136 (Supplement 1): 38.

https://doi.org/10.1182/blood-2020-136013

Published: 2020

Journal Articles

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Yang Liang, PhD, Yun Wang, Yan-Yu Cai, Siliang Chen, Run-Cong Nie, Zhe-Yuan Qin, PhD, Fang Hu, Weida Wang, MD, Yu-Jun Dai, PhD

Blood (2019) 134 (Supplement_1): 708.

https://doi.org/10.1182/blood-2019-126733

Published: 2019

Journal Articles

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Su Li, master's degree, Xianmin Song, MD, Liping Wan, Chun Wang, Yin Tong, Master's degree, Chongmei Huang, MD, Xiaoqian Xu, Master's degree, Yu CAI, MD, Guogang Xie, MD, Rong Tang, MD, Yi Sun, PhD, Aihua Bao, MD, Jun Yang, MD

Blood (2019) 134 (Supplement_1): 4626.

https://doi.org/10.1182/blood-2019-127950

Published: 2019

Journal Articles

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Jun Yang, Jiang Jieling, Yu CAI, MD, Su Li, Liping Wan, Jun Zhu, Huixia Liu, Shan Shao, Haitao Bai, Chun Wang, Jiong Hu, MD, Xianmin Song

Blood (2018) 132 (Supplement 1): 4575.

https://doi.org/10.1182/blood-2018-99-110727

Published: 2018

Journal Articles

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Yu CAI, MD, Chun Wang, Xianmin Song, Liping Wan, Su Li, Jun Yang, Jieling Jiang, MD

Blood (2018) 132 (Supplement 1): 5758.

https://doi.org/10.1182/blood-2018-99-111868

Published: 2018

NARROW

Multicenter, Real-World Experience Study of FLT3-Inhibitor Post-Transplant Maintenance Therapy Following Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia with FLT3-ITD

The Parous Female Donor Is Not Inferior to Young Male Donor for Haploidentical Peripheral Blood Stem Cell Transplantation with Low-Dose ATG Plus Low-Dose Ptcy-Based Regimen for Gvhd Prophylaxis

Multicenter Survey on the Practice Patterns of Post-Transplant Maintenance Treatment in FLT3-ITD Acute Myeloid Leukemia and Philadelphia Positive Acute Lymphoblastic Leukemia: What Is the Common Institutional Policy for Duration of Therapy?

Haploidentical Peripheral Blood Stem Cell Transplantation Improves the Survival of Older Patients with Myeloid Malignancies Under Low-Dose Antithymocyte Globin (ATG)/Post-Cyclophosphamide (PTCy)-Based Regimen for Graft-Versus-Host Disease Prophylaxis

IM2 Regimen Is Effective and Safe for Relapsed or Refractory T-Cell Lymphoblastic Lymphoma/Leukemia

Comparison of Outcomes between Haploidentical and Matched Related Donors for Chronic Myelomonocytic Leukemia: A Multicenter Real-World Study

Multicenter Retrospective Analysis on the Clinical Benefit of Post-Transplant Tyrosine Kinase Inhibitor (TKI) Maintenance Therapy in Ph-Positive Acute Lymphoblastic Leukemia Suggests Improved GvHD-Free, Relapse Free Survival and Non-Relapse Mortality, but Not the Risk of Relapse

Comparing Common Therapies in Polycythemia Vera (PV): A Disproportionality Analysis in the FDA Adverse Event Reporting System (FAERS) Database

A Novel JAK1 Inhibitor SHR0302 for Treatment of Chronic Graft-Verse-Host Disease: A Phase I Clinical Trial

Low-Dose Antithymocyte Globulin Plus Low-Dose Post-Transplant Cyclophosphamide for Prevention of Graft-Versus-Host Disease after Haploidentical Peripheral Blood Stem Cell Transplants: A Large Sample, Long-Term Follow-up Retrospective Study

Phase I Study of SHR0302, a Selective JAK1 Inhibitor, Combined with Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease after Allo-HSCT

Metagenomic Next-Generation Sequencing for Pathogens in Bronchoalveolar Lavage Fluid Improve the Survival of Patients with Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplantation

Results from a Phase 1 Dose Escalation Study of HMPL-689, a Selective Oral Phosphoinositide 3-Kinase-Delta Inhibitor, in Chinese Patients with Relapsed/Refractory (R/R) Lymphomas

Identification of an Immune Risk Score to Predict the Prognosis of Acute Myeloid Leukemia

Diagnosis of Lung Complication in Allogeneic Stem Cell Transplantation By Combined Use of Multiple Methods through Bronchoscopic Alveolar Lavage

Low Dose Anti-Thymocyte Globulin Plus Low Dose Post-Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis in Haploidentical Peripheral Blood Stem Cell Transplantation for Patients with Hematologic Malignancies: A Prospective, Phase II Study

Favorable Overall Survival in Refractory Diffuse Large B-Cell Lymphoma When Responded to High-Dose Etoposide Mobilization Chemotherapy Followed By Autologous Peripheral Blood Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only